Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Meiling Zhang, Yu Bao, Hong Zhang, Dongmei Li, Xinkuan Mei & Xianping Cheng. (2023) Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels. Journal of Obstetrics and Gynaecology 43:1.
Read now
Read now
Min Jin, Jun Cai, Xuan Wang, Tao Zhang & Yingchao Zhao. (2018) Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review. Cancer Biology & Therapy 19:12, pages 1088-1092.
Read now
Read now
Khalid El Bairi, Mariam Amrani, Abdul Hafeez Kandhro & Said Afqir. (2017) Prediction of therapy response in ovarian cancer: Where are we now?. Critical Reviews in Clinical Laboratory Sciences 54:4, pages 233-266.
Read now
Read now
Ioannis Ntanasis-Stathopoulos, George Fotopoulos, Ioannis-Georgios Tzanninis & Elias A. Kotteas. (2016) The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review. Cancer Investigation 34:7, pages 313-339.
Read now
Read now
Articles from other publishers (23)
Zezhou Hao, Pengchen Liang, Changyu He, Shuang Sha, Ziyuan Yang, Yixin Liu, Junfeng Shi, Zhenggang Zhu & Qing Chang. (2022) Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs. BMC Bioinformatics 23:1.
Crossref
Crossref
Yanzi Qin & Wenjun Zhao. (2022) The Modeling Analysis and Effect of CHI3L1 and CD31-Marked Microvessel Density in the Occurrence and Development of Cervical Squamous Cell Carcinoma. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Crossref
Yarely M. Salinas-Vera, Dolores Gallardo-Rincón, Erika Ruíz-García, Laurence A. Marchat, Jesús Valdés, Carlos Vázquez-Calzada & César López-Camarillo. 2022. Vasculogenic Mimicry. Vasculogenic Mimicry
53
60
.
Maria Poplawska, Dibyendu Dutta, Yichun Lee & Seah H. Lim. (2021) Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering. Molecular Therapy - Oncolytics 23, pages 378-386.
Crossref
Crossref
Qipeng Fan, Lihong Li, Tian-Li Wang, Robert E. Emerson & Yan Xu. (2021) A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer. Cancers 13:15, pages 3821.
Crossref
Crossref
Xiaodan Sun, Ji Li, Yizhuo Li, Shouhan Wang & Qingchang Li. (2020) Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Crossref
Brittni Foster, Danish Zaidi, Tyler Young, Mary Mobley & Bethany Kerr. (2018) CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance. Biomedicines 6:1, pages 31.
Crossref
Crossref
Carlotta A. Glackin. 2018. Mesoporous Silica-based Nanomaterials and Biomedical Applications, Part B. Mesoporous Silica-based Nanomaterials and Biomedical Applications, Part B
83
101
.
Ali Flores-Pérez, Dolores Gallardo Rincón, Erika Ruiz-García, Raquel Echavarria, Laurence A. Marchat, Elizbeth Álvarez-Sánchez & César López-Camarillo. 2018. MicroRNA and Cancer. MicroRNA and Cancer
179
186
.
Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, Verónica Corrales-Sánchez, Leticia Serrano-Oviedo, Fernando Andrés-Pretel, Juan Carlos Montero, Miguel Burgos, Juan Llopis, Eva María Galán-Moya, Atanasio Pandiella & Alberto Ocaña. (2017) Synthetic Lethality Interaction Between Aurora Kinases and CHEK1 Inhibitors in Ovarian Cancer. Molecular Cancer Therapeutics 16:11, pages 2552-2562.
Crossref
Crossref
Wenming Liu, Chunping Lv, Bin Zhang, Quansheng Zhou & Zhifei Cao. (2017)
MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of
VE-cadherin
expression
. RNA 23:7, pages 1019-1027.
Crossref
Crossref
Robert L Coleman, Mark F Brady, Thomas J Herzog, Paul Sabbatini, Deborah K Armstrong, Joan L Walker, Byoung-Gie Kim, Keiichi Fujiwara, Krishnansu S Tewari, David M O'Malley, Susan A Davidson, Stephen C Rubin, Paul DiSilvestro, Karen Basen-Engquist, Helen Huang, John K Chan, Nick M Spirtos, Raheela Ashfaq & Robert S Mannel. (2017) Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. The Lancet Oncology 18:6, pages 779-791.
Crossref
Crossref
Carolina Vera, Lorena Or�stica, Fernando Gabler, Arturo Ferreira, Alberto Selman, Margarita Vega & Carmen Romero. (2017) The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells. International Journal of Oncology.
Crossref
Crossref
Yanhua Du, Jun Wu, Haiyan Zhang, Shaobo Li & Hong Sun. (2017) Reduced expression of SIRT2 in serous ovarian carcinoma promotes cell proliferation through disinhibition of CDK4 expression. Molecular Medicine Reports.
Crossref
Crossref
L. Ceppi & M.J. Birrer. 2017. Translational Advances in Gynecologic Cancers. Translational Advances in Gynecologic Cancers
19
34
.
Veronica Rojas, Kim Hirshfield, Shridar Ganesan & Lorna Rodriguez-Rodriguez. (2016) Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment. International Journal of Molecular Sciences 17:12, pages 2113.
Crossref
Crossref
Aniruddha Roy & Shyh‐Dar Li. (2016) Modifying the tumor microenvironment using nanoparticle therapeutics. WIREs Nanomedicine and Nanobiotechnology 8:6, pages 891-908.
Crossref
Crossref
Duong Thanh Nguyen, Yantao Fan, Yasemin M Akay & Metin Akay. (2016) TNP-470 Reduces Glioblastoma Angiogenesis in Three Dimensional GelMA Microwell Platform. IEEE Transactions on NanoBioscience 15:7, pages 683-688.
Crossref
Crossref
Ursula A. Matulonis, Anil K. Sood, Lesley Fallowfield, Brooke E. Howitt, Jalid Sehouli & Beth Y. Karlan. (2016) Ovarian cancer. Nature Reviews Disease Primers 2:1.
Crossref
Crossref
Sonam Sinha, Sajid Khan, Samriddhi Shukla, Amar Deep Lakra, Sudhir Kumar, Gunjan Das, Rakesh Maurya & Syed Musthapa Meeran. (2016) Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis. The International Journal of Biochemistry & Cell Biology 77, pages 41-56.
Crossref
Crossref
Zhang Yue, Zhang Yun-shan & Xue Feng-xia. (2016) miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. Journal of the Renin-Angiotensin-Aldosterone System 17:3, pages 147032031666332.
Crossref
Crossref
J. Krzystyniak, L. Ceppi, D.S. Dizon & M.J. Birrer. (2016) Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer. Annals of Oncology 27, pages i4-i10.
Crossref
Crossref
A. E. Protasova, E. N. Vandeeva & N. S. Kuzmina. (2016) Is endometriosis a benign disease? Modern controversial aspects of endometriosis-associated ovarian tumors. Problemy reproduktsii 22:5, pages 98.
Crossref
Crossref